Results 91 to 100 of about 19,730 (233)

Direct Anterior Approach Total Hip Arthroplasty for Femoral Neck Fractures in the Lateral Position

open access: yesClinical Interventions in Aging
Xiaofei Wang,1,2,* Jihang Dai,2,* Zhimin Wu,1,2 Yuxia Yang,2 Jian Zhang,2 Xiangji Meng,1,2 Wenkang Liu,2 Wenyong Fei,2 Jingcheng Wang2 1The Graduate School, Dalian Medical University, Dalian, Liaoning, People’s Republic of China; 2Department of ...
Wang X   +8 more
doaj  

Seed Germination and Seedling Production of Physalis peruviana Using Different Substrates and Growing Containers

open access: yesCrops
The cultivation of Physalis peruviana has emerged as a promising alternative for small- and medium-sized producers due to its high added value and low production cost.
Elis Marina de Freitas   +3 more
doaj   +1 more source

Amino Acids in the Natural Food Web of Global Fishponds: Way Forward for Precision Protein Feeding in Pond Cyprinid Aquaculture

open access: yesReviews in Aquaculture, Volume 18, Issue 4, September 2026.
ABSTRACT Natural food webs in freshwater pond ecosystems provide an important nutritional foundation for cyprinid aquaculture, yet information on their protein and amino acid composition remains fragmented. This review synthesized published data from 30 studies (1950–2026) reporting protein and indispensable amino acid (IAA) composition of freshwater ...
Md. Foysul Hossain   +5 more
wiley   +1 more source

Trends in long‐term outcomes of patients with HCV‐associated hepatocellular carcinoma after hepatectomy: A comparison before and after introduction of direct‐acting antivirus therapy

open access: yesAnnals of Gastroenterological Surgery
Backgrounds The success of direct‐acting antiviral (DAA) therapy provides a cure for patients chronically infected with hepatitis C virus (HCV); however, outcomes after hepatectomy for HCV‐associated hepatocellular carcinoma (HCC) before and after DAA ...
Fumiaki Munekage   +9 more
doaj   +1 more source

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma‐cfDNA of advanced breast cancer patients: A feasibility proof‐of‐concept study

open access: yesMolecular Oncology, Volume 20, Issue 8, Page 2102-2113, August 2026.
Circulating tumor cells (CTCs) and plasma cell‐free DNA (cfDNA) were analyzed to detect ESR1 mutations and methylation in patients with advanced breast cancer. CTC‐derived DNA showed higher sensitivity for mutation detection and revealed complementary genetic and epigenetic alterations, highlighting the added value of CTC analysis for understanding ...
Dimitra Stergiopoulou   +12 more
wiley   +1 more source

Dipole‐Manipulated Built‐In Electric Field Enables Ultrafast Charge Separation in Perylene Diimide Polymers for Photoelectrochemical Water Splitting

open access: yesAdvanced Science, Volume 13, Issue 43, 3 August 2026.
Molecular dipole engineering in dendritic perylene diimide polymers through nitrogen‐rich heterocyclic linkers amplifies the built‐in electric field, enabling sub‐picosecond charge separation and efficient multi‐electron accumulation. This structure–dynamics–performance relationship establishes a versatile design strategy for high‐performance organic ...
Ying‐Xin Qiao   +11 more
wiley   +1 more source

IMPLEMENTASI METODE DAKWAH ISLAM ALA NABI MUHAMMAD SAW DI INDONESIA

open access: yesKomunika, 2016
Da’wa methodology is an important aspect in Islamic missionary. It formulates, create, and determine the most relevant methods of da’wa in regards with the need of its audience (mad’u). It is necessary for da’wa to have a figure, actor, or agent
Enung Asmaya
doaj  

Science that speaks: The public face of physiology

open access: yes
Experimental Physiology, EarlyView.
Danny W. Walmsley   +4 more
wiley   +1 more source

Bemnifosbuvir: An HCV NS5B Inhibitor With Multiple Modes of Action

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 2, Page 552-562, August 2026.
Bemnifosbuvir (BEM) is a potent, pan‐genotypic inhibitor targeting the hepatitis C virus (HCV) NS5B polymerase. Its antiviral activity was evaluated in an ascending dose phase I clinical trial involving 30 patients treated once a day for 7 days. After treatment initiation, plasma HCV RNA declined in a biphasic manner with a mean reduction of 2.3 log10 ...
Carolin Zitzmann   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy